Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Multiple sclerosis treatment: risk mitigation.
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.
Sexual dimorphism in the aged rat CD4+ T lymphocyte-mediated immune response elicited by inoculation with spinal cord homogenate.
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
Neuromuscular manifestations of west nile virus infection.
Different MOG35-55 concentrations induce distinguishable inflammation through early regulatory response by IL-10 and TGF-β in mice CNS despite unchanged clinical course.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
White matter disease: Early treatment of inflammatory demyelinating disease.
A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Brace: A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies.
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Quality of life and coping strategies in Lebanese Multiple Sclerosis patients: A pilot study.
Psychological well-being in people with multiple sclerosis in an Iranian population.
TNF-alpha promotes cerebral pericyte remodeling in vitro, via a switch from alpha1 to alpha2 integrins.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »